James Tabery, a professor at the University of Utah, joins host Krys Boyd to discuss why precision medicines focused on gene technology benefit only the rich, while average citizens are left behind in this new model of curing disease.
Read more
The big business of blood: Exploitation in the plasma industry
Journalist Kathleen McLaughlin shares her research into where blood plasma really comes from – a journey through the for-profit blood industry that stretches all the way to China.
Read more